FdaApplication
ANDA 219395
Identifiers
- fda_app_no: ANDA219395
Properties
| Property | Value |
|---|---|
| applicant_name | SPECGX LLC |
| application_type | ANDA |
| approval_date | 2026-06-03 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 10MG BASE | TABLET;ORAL |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | EQ 5MG BASE | TABLET;ORAL |
2 products